Real Time Screeners Intraday Screeners now on Real Time Data (Updated every 5 mins)
Stock Listing : A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z 

Stock Analysis of Glenmark Pharmaceuticals , Birds-Eye-view On Returns/Technicals/Funda/F&O

About Strength Screener

Charts Of Glenmark Pharmaceuticals Ltd.

1D   1W   2W   1M   3M   1Y   2Y   5Y   
Interactive Charts

Price / Volume Action

EOD Share Price426.65
Previous Share Price431.95
Price Change -5.30
Change % -1.23%
Volume3395.20 K
Five Day Avg Vol3912.56 K
Fno StockYes, F&O list
Last Business Date10-Jul-20

Price Gain/Loss

DurationAbsolute ChgChg %
One Week -6.05 -1.40
Two Weeks -40.05 -8.58
One Month 25.20 6.28
Three Months 179.00 72.28
Six Months 80.25 23.17
One Year -19.25 -4.32
Compare GLENMARK with Peers/ Index

Highs / Lows

One Week439.35415.0
Two Weeks484.7415.0
One Month573.05371.0
Three Months573.05253.0
Six Months573.05161.65
One Year573.05161.65

Key Moving Average

5 Days 424.49427.769
15 Days 448.83430.973
20 Days 436.725427.368
50 Days 389.332393.973
100 Days 329.549363.946
200 Days 329.039367.078
Detailed MA Analysis of GLENMARK ...

Key Technical Indicators

MACD 10.69
RSI 17.56
RSI (Smooth) 52.35
ADX 32.63
Chaikin Money Flow -0.223
Williams %R -91.37
PSAR 552.24
Detailed Tech Analysis GLENMARK ...

Financial Data Highlights

Market Cap12033.15
Book Value/ Share215.202
Enterprise Value2386.99
Revenue TTM10640.97
Gross Profit TTM6942.33
Revenue /Share TTM377.11
Consensus Target663.61
Key Financial Highlights GLENMARK ...

Financial Ratios of GLENMARK

Div Yield0.460
Trailing PE17.85
Forward PE12.95
Key Financial Ratios of GLENMARK ...

Key Profit & Loss Data

Net Inc 0 100.00 %
Ops Income0 100.00 %
Revenue0 100.00 %
Ops Expense0 100.00 %
PBT0 100.00 %
Gross Profit0 100.00 %
Div Paid0 100.00 %

Futures of GLENMARK

Closing Price428.50
Premium/Discount 1.85
Price Change -7.50
Change % -1.72
Future OI4866.80 K
OI Change % -0.750
Future Contracts17.00
Contracts Change -78.21
Lot Size2300

Put / Call Options

Call Max Traded Strike Price450.00
Call Max Traded SP Contracts11
Call Option Open Interest3176.30 K
Call Option OI Chg % 1.69
Put Max Traded Strike Price450.00
Put Max Traded SP Contracts4
Put Option Open Interest2093.00 K
Put Option OI Chg % -13.50
Option Chain With Impled Vol & Greeks ...

Put Call Ratio - 30/07/2020

Put Open Interest2093.00 K
Call Open Interest3176.30 K
PCR Open Interest0.659
PCR OI ReadingNeutral
Put Contracts Traded16.00
Call Contracts Traded45.00
PCR Volume0.356
PCR Vol ReadingStrong Bullish
Put Call Ratio GLENMARK ...

Price Range (PR) /Volatility

PeriodAvg PR Range %
LBD PR14.403.38
Week PR24.355.71
Month PR30.007.03
5 Day Period12.563.00
10 Day Period13.623.19
5 Week Period62.7014.80
3 Months Period123.4034.04
Price Range /Volatility GLENMARK ...

Highlights & Chart Patterns of Glenmark Pharmaceuticals Ltd.

Share has hit One Week high on 10-Jul-20.
Stock has jumped by more than 25% in last three Month from its lowest level of 253.0 dt 13-Apr-20.
Stock has jumped by more than 50% in last Six Month from its lowest level of 161.65 dt 13-Mar-20.
Stock has jumped by more than 100% in last One Year from its lowest level of 161.65 dt 13-Mar-20.
Stock has fallen by more than 10% in last two weeks from its highest level of 484.7 dt 29-Jun-20.
Stock has fallen by more than 15% in last One Month from its highest level of 573.05 dt 22-Jun-20.
As Per ADX, stock is in trend with ADX of 32.6267 and is trending for 85 Days
More Chart Patterns Glenmark Pharmaceuticals Ltd. ...
You can now customize Equity with technical , SMA , Fin Data, chart patterns in one Page. Click here to view guide

Share Price History of Glenmark Pharmaceuticals Ltd.

Date Open High Low Close Volume
10-Jul-20 432.25 439.35 424.95 426.65 3395 K
09-Jul-20 423.00 434.45 420.45 431.95 5093 K
08-Jul-20 415.50 425.00 415.15 419.35 3660 K
07-Jul-20 427.00 427.00 415.00 416.50 4590 K
06-Jul-20 433.00 436.00 426.60 428.00 2823 K
03-Jul-20 436.10 439.50 430.50 432.70 3320 K
02-Jul-20 433.00 442.20 428.10 435.25 6183 K
01-Jul-20 445.00 445.00 423.90 435.20 21051 K
30-Jun-20 462.00 464.80 446.10 450.30 10571 K
29-Jun-20 474.90 484.70 465.10 467.80 14878 K
About Glenmark Pharmaceuticals Limited
Glenmark Pharmaceuticals Limited, together with its subsidiaries, develops, manufactures, and markets pharmaceutical products in India, North America, Latin America, Europe, and internationally. The company provides branded and generic formulations in therapeutic areas of dermatology, respiratory, and oncology; and various active pharmaceutical ingredients. Its product pipeline includes GBR 830, which is in Phase 2b clinical trails for the treatment of atopic dermatitis; GRC 27864 that is in Phase 2b clinical trails for the treatment of osteoarthritic pain; and GRC 17536, which has completed Phase 2a clinical trails for the treatment of painful diabetic neuropathy. The company's products pipeline comprises GBR 1302, which is in Phase 1a/1b clinical trails for the treatment of breast cancer; and GBR 1342 that is in Phase 1a/1b clinical trails for the oncology; GRC 5xxxx, a MAP4K1 inhibitor compound, which is in pre-clinical studies for the treatment of cancer; and Ryaltris for allergic rhinitis. The company was founded in 1977 and is based in Mumbai, India.
About Strength

Strength is based on Deep Analysis, Back Testing and Historical Trend Analysis using Machine Learning. Overall Technical Strength is based on 50+ indicators including Technicals, moving Avg, chart patterns, candlestick and proprietary algorithms.Technical Strength is currently calculated around around 5 to 6 PM. This is an automated process and in NO WAY should be considered as a tip as its based on past data. We strongly recommend to use these signals for information only and seek advise from a certified professional for any trading decision.If you like it then please share. The more the visitors the more the innovations. Feedback

We are working on fundamental strength also. Please share your views to help shape up the requirement.

( Intraday Analysis is on Real Time Data (Updated every 5 Mins). All Other analysis is based on End of Trade day's Value. Expected time of update is between 5 to 5.30 PM exchange time Zone)

All Rights Reserved By Mintnovate Market Research Pvt Ltd.